A SARS-CoV-2 NFC ePAD Biosensor
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 3R01EB031510-01S1
Grant search
Key facts
Disease
COVID-19Start & end year
20212023Known Financial Commitments (USD)
$58,053Funder
National Institutes of Health (NIH)Principal Investigator
PROFESSOR DAVID DANDYResearch Location
United States of AmericaLead Research Institution
COLORADO STATE UNIVERSITYResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Proposed here is the development of an improved electrochemical sensor for detection of the SARS-CoV-2 nucleocapsid protein using thermoplastic electrodes (TPEs). The need for faster testing amid the COVID-19 pandemic brought about several alternatives to RT-qPCR testing for viral infections. However, current rapid tests are lacking in sensitivity (lateral flow assays and other paper based tests) or expensive (gold based electrochemical tests). TPEs solve both the sensitivity and cost issues and have been shown to be more robust than stencil printed carbon electrodes (SPCE). The TPE surfaces will be covalently modified using electroreduction of aryldiazonium salts followed by "click chemistry" to provide a platform for simple antibody crosslinking reactions. The fully characterized and functional sensor will then be the basis for future work integrating it into a microfluidic device for a full on-chip assay.